Better Marijuana Stock: Canopy Growth vs. Aphria
During the coronavirus pandemic, many U.S. locales deemed cannabis an essential item, and the resultant surge in sales brought revenue pouring in for several marijuana companies. But the same can't be said about the Canadian market. While that country also declared cannabis essential, changes in consumer sentiment, supply challenges, and consumers pivoting toward the illicit market were among the reasons revenue growth slowed north of the border.
That said, revenue does seem to be rising for two Canadian pot companies: Canopy Growth (NYSE: CGC) and Aphria (NASDAQ: APHA). And while shares of these two companies have fallen by 20% and 12.2%, respectively, so far this year, both are actually doing a little better than the benchmark Horizons Marijuana Life Sciences ETF's decline of 25%.
Profitability, leadership teams, and balance-sheet strength are just some of the factors investors should consider when choosing between these two marijuana stocks.
Source Fool.com
